Compounds > imiquimod
Page last updated: 2024-08-24

imiquimod and Diathesis

imiquimod has been researched along with Diathesis in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (77.78)24.3611
2020's2 (22.22)2.80

Authors

AuthorsStudies
Bassaganya-Riera, J; Chauhan, J; Hontecillas, R; Leber, A; Maturavongsadit, P; Tubau-Juni, N1
Bae, EJ; Hao, L; Kwon, BM; Mao, Y; Park, BH; Park, J1
Ahmad, SF; Al-Harbi, NO; Attia, SM; Bakheet, SA; El-Sherbeeny, AM; Nadeem, A1
Han, D; Hwang, ST; Jena, PK; Sheng, L; Wan, YJY; Wu, X; Yu, S; Zhou, Y1
Cho, SD; Han, JH; Kang, MJ; Kim, B; Kim, BY; Kim, DJ; Kim, JB; Park, JH; Park, SY1
Abbatiello, B; Ajami, NJ; Belkaid, Y; Chen, Q; Chen, W; Chen, ZJ; Chia, C; Jiao, X; Kasagi, S; Konkel, JE; Nakatsukasa, H; Petrosino, JF; Smith, DP; Wu, R; Zanvit, P; Zhang, D1
Finkelstein, D; Gangwar, R; Gingras, S; Häcker, H; Ippagunta, SK; Pelletier, S; Redecke, V; Vogel, P1
Cheng, G; Deng, JC; Ghaffari, AA; Lung, WY; Meyerson, C; Tian, X; Xu, F1
de Troya-Martín, M; Del Boz, J; Fernández-Morano, T; Frieyro-Elichegui, M; Padilla-España, L; Repiso, JB1

Reviews

1 review(s) available for imiquimod and Diathesis

ArticleYear
[Treatment of anogenital warts with topical cidofovir].
    Enfermedades infecciosas y microbiologia clinica, 2013, Volume: 31, Issue:4

    Topics: Administration, Topical; Adult; Aminoquinolines; Antiviral Agents; Anus Diseases; Child; Cidofovir; Combined Modality Therapy; Condylomata Acuminata; Cryotherapy; Cytosine; Disease Susceptibility; Drug Evaluation; Drug Resistance, Viral; Electrocoagulation; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Imiquimod; Immunocompetence; Male; Organophosphonates; Podophyllotoxin; Remission Induction; Retrospective Studies; Young Adult

2013

Other Studies

8 other study(ies) available for imiquimod and Diathesis

ArticleYear
First-in-class topical therapeutic omilancor ameliorates disease severity and inflammation through activation of LANCL2 pathway in psoriasis.
    Scientific reports, 2021, 10-06, Volume: 11, Issue:1

    Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Disease Susceptibility; Imiquimod; Immunosuppressive Agents; Inflammation Mediators; Keratinocytes; Membrane Proteins; Mice; Mice, Knockout; Phosphate-Binding Proteins; Psoriasis; Signal Transduction; T-Lymphocyte Subsets

2021
2'-Hydroxycinnamaldehyde ameliorates imiquimod-induced psoriasiform inflammation by targeting PKM2-STAT3 signaling in mice.
    Experimental & molecular medicine, 2021, Volume: 53, Issue:5

    Topics: Animals; Biomarkers; Cell Survival; Cinnamates; Cytokines; Disease Management; Disease Models, Animal; Disease Susceptibility; Imiquimod; Mice; Psoriasis; Pyruvate Kinase; Signal Transduction; STAT3 Transcription Factor; T-Lymphocyte Subsets; Th17 Cells

2021
Systemic inflammation in asocial BTBR T
    Progress in neuro-psychopharmacology & biological psychiatry, 2018, 04-20, Volume: 83

    Topics: Adaptive Immunity; Animals; Arthritis, Psoriatic; Autism Spectrum Disorder; Disease Models, Animal; Disease Susceptibility; Imiquimod; Immunity, Innate; Inflammation; Male; Membrane Glycoproteins; Mice, Inbred C57BL; Skin; Social Behavior; Species Specificity; Th17 Cells; Toll-Like Receptor 7

2018
A Western Diet, but Not a High-Fat and Low-Sugar Diet, Predisposes Mice to Enhanced Susceptibility to Imiquimod-Induced Psoriasiform Dermatitis.
    The Journal of investigative dermatology, 2019, Volume: 139, Issue:6

    Topics: Animals; Diet, Carbohydrate-Restricted; Diet, High-Fat; Diet, Western; Dietary Sugars; Disease Models, Animal; Disease Susceptibility; Female; Humans; Imiquimod; Mice; Obesity; Psoriasis

2019
TLR7 expression is decreased during tumour progression in transgenic adenocarcinoma of mouse prostate mice and its activation inhibits growth of prostate cancer cells.
    American journal of reproductive immunology (New York, N.Y. : 1989), 2013, Volume: 70, Issue:4

    Topics: Adenocarcinoma; Aminoquinolines; Animals; Antineoplastic Agents; Carcinogenesis; Cell Growth Processes; Cell Line, Tumor; Cytokines; Disease Models, Animal; Disease Susceptibility; Epithelial Cells; Gene Expression Regulation, Neoplastic; Guanosine; Humans; Imiquimod; Inflammation Mediators; Macrophages; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Prostate; Prostatic Neoplasms; Toll-Like Receptor 7; Transgenes; Tumor Stem Cell Assay

2013
Antibiotics in neonatal life increase murine susceptibility to experimental psoriasis.
    Nature communications, 2015, Sep-29, Volume: 6

    Topics: Aminoquinolines; Animals; Animals, Newborn; Anti-Bacterial Agents; Disease Susceptibility; Drug Interactions; Imiquimod; Interleukin-17; Interleukin-22; Interleukins; Mice; Mice, Inbred C57BL; Microbiota; Polymyxin B; Psoriasis; Skin; T-Lymphocytes; Vancomycin

2015
Keratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function.
    Proceedings of the National Academy of Sciences of the United States of America, 2016, 10-11, Volume: 113, Issue:41

    Topics: Aminoquinolines; Animals; Disease Models, Animal; Disease Susceptibility; DNA-Binding Proteins; Female; Gene Expression Profiling; Imiquimod; Interleukin-17; Interleukin-23; Keratinocytes; Lymphocytes; Male; Mice; Mice, Knockout; Psoriasis; Transcriptome

2016
Poly I:C enhances susceptibility to secondary pulmonary infections by gram-positive bacteria.
    PloS one, 2012, Volume: 7, Issue:9

    Topics: Aminoquinolines; Animals; Antibodies; Antigens, Viral; Disease Susceptibility; Gene Expression Regulation; Imidazoles; Imiquimod; Interferon Inducers; Interferon Type I; Membrane Proteins; Methicillin-Resistant Staphylococcus aureus; Mice; Nerve Tissue Proteins; Pneumococcal Infections; Pneumonia, Bacterial; Poly I-C; Receptor, Interferon alpha-beta; Receptors, Cell Surface; Signal Transduction; Staphylococcal Infections; Streptococcus pneumoniae; Survival Rate; Toll-Like Receptor 3

2012